排序方式:
1.Upgrade of chrysomycin A as a novel topoisomerase II inhibitor to curb KRAS-mutant lung adenocarcinoma progression
Zhang, JM, Liu, P, C
More...
Zhang, JM, Liu, P, Chen, JW, Yao, DH, Liu, Q, Zhang, JH, Zhang, HW, Leung, ELH, Yao, XJ, Liu, L
Less
PHARMACOLOGICAL RESEARCH[1043-6618],
Published 2023,
Volume 187,
收錄情况:
WOS
SCOPUS
WOS核心合集引用: 1
2022影響因子:
9.3
2.Andrographolide suppresses non-small-cell lung cancer progression through induction of autophagy and antitumor immune response
Wang, XuanRun, Jiang
More...
Wang, XuanRun, Jiang, ZeBo, Xu, Cong, Meng, WeiYu, Liu, Pei, Zhang, YiZhong, Xie, Chun, Xu, JingYi, Xie, YaJia, Liang, TuLiang, Yan, HaoXin, Fan, XingXing, Yao, XiaoJun, Wu, QiBiao, Leung, Elaine LaiHan
Less
Pharmacological Research[1043-6618],
Published 2022,
Volume 179,
收錄情况:
WOS
SCOPUS
WOS核心合集引用: 18
2022影響因子:
9.3
发表年影響因子:
9.3
3.Down-regulating Nrf2 by tangeretin reverses multiple drug resistance to both chemotherapy and EGFR tyrosine kinase inhibitors in lung cancer
Xie, Y, Feng, SL, He
More...
Xie, Y, Feng, SL, He, F, Yan, PY, Yao, XJ, Fan, XX, Leung, ELH, Zhou, H
Less
PHARMACOLOGICAL RESEARCH[1043-6618],
Published 2022,
Volume 186,
收錄情况:
WOS
SCOPUS
WOS核心合集引用: 4
2022影響因子:
9.3
发表年影響因子:
9.3
4.Plumbagin suppresses non-small cell lung cancer progression through downregulating ARF1 and by elevating CD8+ T cells
Jiang, ZeBo, Xu, Con
More...
Jiang, ZeBo, Xu, Cong, Wang, Wenjun, Zhang, YiZhong, Huang, JuMin, Xie, YaJia, Wang, QianQian, Fan, XingXing, Yao, XiaoJun, Xie, Chun, Wang, XuanRun, Yan, PeiYu, Ma, YuPo, Wu, QiBiao, Leung, Elaine LaiHan
Less
Pharmacological Research[1043-6618],
Published 2021,
Volume 169,
收錄情况:
WOS
SCOPUS
WOS核心合集引用: 8
2022影響因子:
9.3
发表年影響因子:
10.334
5.Selectively targeting individual bromodomain: Drug discovery and molecular mechanisms
Wang, QQ, Shao, XM,
More...
Wang, QQ, Shao, XM, Leung, ELH, Chen, YQ, Yao, XJ
Less
PHARMACOLOGICAL RESEARCH[1043-6618],
Published 2021,
Volume 172,
收錄情况:
WOS
SCOPUS
WOS核心合集引用: 12
2022影響因子:
9.3
发表年影響因子:
10.334
6.Network pharmacological approach for elucidating the mechanisms of traditional Chinese medicine in treating COVID-19 patients
Pan, HuDan, Yao, Xia
More...
Pan, HuDan, Yao, XiaoJun, Wang, WanYing, Liu, Liang, Lau, HungYan
Less
Pharmacological Research[1043-6618],
Published 2020,
Volume 159,
收錄情况:
WOS
SCOPUS
WOS核心合集引用: 13
2022影響因子:
9.3
发表年影響因子:
7.658
7.Chelidonine selectively inhibits the growth of gefitinib-resistant non-small cell lung cancer cells through the EGFR-AMPK pathway
Xie, YaJia, Gao, Wei
More...
Xie, YaJia, Gao, WeiNa, Wu, QiBiao, Yao, XiaoJun, Jiang, ZeBo, Wang, YuWei, Wang, WenJun, Hussain, Shahid, Liu, Liang, Leung, Elaine LaiHan, Fan, XingXing, Li, Wei
Less
Pharmacological Research[1043-6618],
Published 2020,
Volume 159,
收錄情况:
WOS
SCOPUS
WOS核心合集引用: 19
2022影響因子:
9.3
发表年影響因子:
7.658
8.Dolutegravir derivative inhibits proliferation and induces apoptosis of non-small cell lung cancer cells via calcium signaling pathway
Wang, WenJun, Lai, H
More...
Wang, WenJun, Lai, HuanLing, Wang, YuWei, Jiang, ZeBo, Huang, JuMin, Xie, YaJia, Xu, Cong, Liu, Pei, Leung, Elaine Lai Han, Yao, XiaoJun, Mao, LongFei, Li, YueMing, Li, Wei
Less
Pharmacological Research[1043-6618],
Published 2020,
Volume 161,
收錄情况:
WOS
SCOPUS
WOS核心合集引用: 21
2022影響因子:
9.3
发表年影響因子:
7.658
9.Cordycepin Inhibits Drug-resistance Non-small Cell Lung Cancer Progression by Activating AMPK Signaling Pathway
Wei, Chunli, Yao, Xi
More...
Wei, Chunli, Yao, Xiaojun, Jiang, Zebo, Wang, Yuwei, Chen, Xi, Fan, Xingxing, Xie, Chun, Fu, Junjiang, Leung, Elaine LaiHan, Zhang, Dianzheng, Cheng, Jingliang
Less
Pharmacological Research[1043-6618],
Published 2019,
Volume 144,
Pages 79-89
收錄情况:
WOS
SCOPUS
WOS核心合集引用: 60
2022影響因子:
9.3
发表年影響因子:
5.893
10.Shikonin inhibits gefitinib-resistant non-small cell lung cancer by inhibiting TrxR and activating the EGFR proteasomal degradation pathway
Li, X, Fan, XX, Jian
More...
Li, X, Fan, XX, Jiang, ZB, Loo, WTY, Yao, XJ, Leung, ELH, Chow, LWC, Liu, L
Less
PHARMACOLOGICAL RESEARCH[1043-6618],
Published 2017,
Volume 115,
Pages 45-55
收錄情况:
WOS
SCOPUS
WOS核心合集引用: 66
2022影響因子:
9.3
发表年影響因子:
4.897
11.Tangeretin, a citrus pentamethoxyflavone, antagonizes ABCB1-mediated multidrug resistance by inhibiting its transport function
Feng, SL, Yuan, ZW,
More...
Feng, SL, Yuan, ZW, Yao, XJ, Ma, WZ, Liu, L, Liu, ZQ, Xie, Y
Less
PHARMACOLOGICAL RESEARCH[1043-6618],
Published 2016,
Volume 110,
Pages 193-204
收錄情况:
WOS
SCOPUS
WOS核心合集引用: 29
2022影響因子:
9.3
发表年影響因子:
4.480
12.Tangeretin, a citrus pentamethoxyflavone, antagonizes ABCB1-mediated multidrug resistance by inhibiting its transport function (vol 110, pg 193, 2016)
Feng, SL, Yuan, ZW,
More...
Feng, SL, Yuan, ZW, Yao, XJ, Ma, WZ, Liu, L, Liu, ZQ, Xie, Y
Less
PHARMACOLOGICAL RESEARCH[1043-6618],
Published 2016,
Volume 111,
Pages 545-545
收錄情况:
WOS
SCOPUS
WOS核心合集引用: 0
2022影響因子:
9.3
发表年影響因子:
4.480
13.Advanced research technology for discovery of new effective compounds from Chinese herbal medicine and their molecular targets
Wong, VKW, Law, BYK,
More...
Wong, VKW, Law, BYK, Yao, XJ, Chen, X, Xu, SW, Liu, L, Leung, ELH
Less
PHARMACOLOGICAL RESEARCH[1043-6618],
Published 2016,
Volume 111,
Pages 546-555
收錄情况:
WOS
SCOPUS
WOS核心合集引用: 17
2022影響因子:
9.3
发表年影響因子:
4.480